TOI
Oncology Institute Inc/the
$1.17
Earnings Summary
Revenue | $85.79Mn |
Net Profits | $-15.31Mn |
Net Profit Margins | -17.85% |
Highlights
Oncology Institute Inc/the’s revenue jumped 20.11% since last year same period to $85.79Mn in the Q4 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated 4.57% jump in its revenue since last 3-months.
Oncology Institute Inc/the’s net profit fell -61.17% since last year same period to $-15.31Mn in the Q4 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated 12.08% jump in its net profits since last 3-months.
Oncology Institute Inc/the’s net profit margin fell -34.18% since last year same period to -17.85% in the Q4 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated 15.93% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Oncology Institute Inc/the post its latest quarter earnings
EPS Estimate Current Quarter | -0.12 |
EPS Estimate Current Year | -0.12 |
Highlights
Oncology Institute Inc/the’s earning per share (EPS) estimates for the current quarter stand at -0.12 - a -9.09% fall from last quarter’s estimates.
Oncology Institute Inc/the’s earning per share (EPS) estimates for the current year stand at -0.12.
Key Ratios
Key ratios of the Oncology Institute Inc/the post its Q4 2023 earnings
Earning Per Share (EPS) | -0.21 |
Highlights
Oncology Institute Inc/the’s earning per share (EPS) jumped 16% since last year same period to -0.21 in the Q4 2023. This indicates that the Oncology Institute Inc/the has generated 16% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.17 | -0.19 | -11.76% |
2024-03-28 | -0.11 | -0.21 | -90.91% |
2023-11-08 | -0.13 | -0.19 | -46.15% |
2023-05-10 | -0.17 | -0.33 | -94.12% |
₹0 US Stocks a/c Opening Fee